Patents by Inventor Subba R Katamreddy

Subba R Katamreddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLIN-DEPENDENT KINASE INHIBITORS
    Publication number: 20230065740
    Abstract: Described herein are compounds and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, methods of treatment, and medical uses. The compounds described herein are modulators of cyclin-dependent kinases, and are useful in the treatment or alleviation of protein kinase associated disorders, including cancer, infectious diseases, autoimmune diseases, or cardiovascular diseases.
    Type: Application
    Filed: December 27, 2019
    Publication date: March 2, 2023
    Inventors: Subba R. KATAMREDDY, Yousry SAYED, Naresh RAMIREDDY
  • CYCLIN-DEPENDENT KINASE INHIBITORS
    Publication number: 20230048132
    Abstract: Described herein are compounds and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, methods of treatment, and medical uses. The compounds described herein are modulators of cyclin-dependent kinases, and are useful in the treatment or alleviation of protein kinase associated disorders, including cancer, infectious diseases, autoimmune diseases, or cardiovascular diseases.
    Type: Application
    Filed: December 27, 2019
    Publication date: February 16, 2023
    Inventors: Subba R. KATAMREDDY, Yousry SAYED, Naresh RAMIREDDY
  • CYCLIN-DEPENDENT KINASE INHIBITORS
    Publication number: 20220220103
    Abstract: Described herein are compounds and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, methods of treatment, and medical uses. The compounds described herein are modulators of cyclin-dependent kinases, and are useful in the treatment or alleviation of protein kinase associated disorders, including cancer, infectious diseases, autoimmune diseases, or cardiovascular diseases.
    Type: Application
    Filed: December 27, 2019
    Publication date: July 14, 2022
    Inventors: Subba R. KATAMREDDY, Yousry SAYED, Naresh RAMIREDDY
  • CYCLIN-DEPENDENT KINASE INHIBITORS
    Publication number: 20220056037
    Abstract: Described herein are compounds and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, methods of treatment, and medical uses. The compounds described herein are modulators of cyclin-dependent kinases, and are useful in the treatment or alleviation of protein kinase associated disorders, including cancer, infectious diseases, autoimmune diseases, or cardiovascular diseases.
    Type: Application
    Filed: December 27, 2019
    Publication date: February 24, 2022
    Inventors: Subba R. KATAMREDDY, Yousry SAYED, Naresh RAMIREDDY
  • Chemical compounds
    Patent number: 8222261
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: July 17, 2012
    Assignee: GlaxoSmithKline, LLC
    Inventors: Subba R Katamreddy, Richard Dama Caldwell, Dennis Heyer, Vincente Samano, James Benjamin Thompson, Andrew J Carpenter, Christopher R Conlee, Eric Eugene Boros, Brian D Thompson
  • CHEMICAL COMPOUNDS
    Publication number: 20090318477
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Application
    Filed: July 12, 2007
    Publication date: December 24, 2009
    Inventor: Subba R. KATAMREDDY